Covered recipient · General Payments record
BANU MYNENI
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2020–2024
$3,876.11
- Reported across 107 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Travel and Lodging | $1,740.89 | 6 |
| Food and Beverage | $836.26 | 21 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Moderna TX, Inc. | $2,346.89 | 16 |
| Novo Nordisk AS | $66.35 | 3 |
| ABBVIE INC. | $51.57 | 3 |
| Abbott Laboratories | $25.62 | 1 |
| PFIZER INC. | $24.39 | 1 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $22.48 | 1 |
| Astellas Pharma US Inc | $21.33 | 1 |
| Lilly USA, LLC | $18.52 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (27)
Sorted by paying entity, then date · as published by CMS
Program year 2024 2020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $25.62 | 06/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125267780 | CMS |
| ABBVIE INC. | $21.85 | 06/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105090419 | CMS |
| ABBVIE INC. | $16.51 | 07/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105090421 | CMS |
| ABBVIE INC. | $13.21 | 09/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105090423 | CMS |
| Astellas Pharma US Inc | $21.33 | 03/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139330236 | CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $22.48 | 02/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118150477 | CMS |
| Lilly USA, LLC | $18.52 | 04/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136060856 | CMS |
| ModernaTX, Inc. | $537.75 | 01/04/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1152560110 | CMS |
| ModernaTX, Inc. | $191.30 | 01/04/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1152560112 | CMS |
| ModernaTX, Inc. | $150.00 | 01/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152560114 | CMS |
| ModernaTX, Inc. | $217.35 | 01/04/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1152560116 | CMS |
| ModernaTX, Inc. | $50.00 | 01/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152560118 | CMS |
| ModernaTX, Inc. | $25.00 | 01/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152560120 | CMS |
| ModernaTX, Inc. | $50.00 | 01/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152560122 | CMS |
| ModernaTX, Inc. | $25.00 | 01/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152560124 | CMS |
| ModernaTX, Inc. | $288.96 | 09/14/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1152560162 | CMS |
| ModernaTX, Inc. | $240.00 | 09/14/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1152560164 | CMS |
| ModernaTX, Inc. | $265.53 | 09/14/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1152560190 | CMS |
| ModernaTX, Inc. | $30.00 | 09/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152560196 | CMS |
| ModernaTX, Inc. | $81.00 | 09/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152560198 | CMS |
| ModernaTX, Inc. | $30.00 | 09/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152560200 | CMS |
| ModernaTX, Inc. | $45.00 | 09/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152560202 | CMS |
| ModernaTX, Inc. | $120.00 | 09/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152560204 | CMS |
| Novo Nordisk Inc | $22.01 | 05/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096866642 | CMS |
| Novo Nordisk Inc | $19.88 | 08/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096941788 | CMS |
| Novo Nordisk Inc | $24.46 | 11/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097578870 | CMS |
| PFIZER INC. | $24.39 | 03/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131645088 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2020, 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.